Free Trial

NeuroOne Medical Technologies (NMTC) Competitors

NeuroOne Medical Technologies logo
$0.90 0.00 (-0.38%)
As of 03:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NMTC vs. SGHT, PROF, TLSI, INGN, BSGM, KRMD, ELMD, PDEX, LNSR, and RCEL

Should you be buying NeuroOne Medical Technologies stock or one of its competitors? The main competitors of NeuroOne Medical Technologies include Sight Sciences (SGHT), Profound Medical (PROF), TriSalus Life Sciences (TLSI), Inogen (INGN), Biosig Technologies (BSGM), KORU Medical Systems (KRMD), Electromed (ELMD), Pro-Dex (PDEX), LENSAR (LNSR), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

NeuroOne Medical Technologies vs. Its Competitors

Sight Sciences (NASDAQ:SGHT) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

Sight Sciences has a net margin of -63.24% compared to NeuroOne Medical Technologies' net margin of -75.41%. Sight Sciences' return on equity of -54.62% beat NeuroOne Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sight Sciences-63.24% -54.62% -34.92%
NeuroOne Medical Technologies -75.41%-334.64%-124.42%

In the previous week, Sight Sciences had 3 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 5 mentions for Sight Sciences and 2 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.94 beat Sight Sciences' score of 0.46 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sight Sciences
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
NeuroOne Medical Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

NeuroOne Medical Technologies has lower revenue, but higher earnings than Sight Sciences. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sight Sciences$79.87M2.27-$51.51M-$0.98-3.57
NeuroOne Medical Technologies$5.76M7.77-$12.32M-$0.22-4.08

Sight Sciences presently has a consensus target price of $3.93, suggesting a potential upside of 12.38%. NeuroOne Medical Technologies has a consensus target price of $1.45, suggesting a potential upside of 61.47%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Sight Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sight Sciences
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29
NeuroOne Medical Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

55.5% of Sight Sciences shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 30.9% of Sight Sciences shares are owned by insiders. Comparatively, 8.9% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Sight Sciences has a beta of 2.47, suggesting that its stock price is 147% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500.

Summary

Sight Sciences beats NeuroOne Medical Technologies on 10 of the 16 factors compared between the two stocks.

Get NeuroOne Medical Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMTC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NMTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NMTC vs. The Competition

MetricNeuroOne Medical TechnologiesMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$44.74M$7.21B$5.72B$9.52B
Dividend YieldN/A2.81%4.60%3.99%
P/E Ratio-4.0824.8128.0720.02
Price / Sales7.7739.20462.58104.32
Price / CashN/A28.2736.5558.97
Price / Book29.939.718.645.90
Net Income-$12.32M$236.91M$3.24B$258.50M
7 Day Performance5.65%2.72%4.08%2.12%
1 Month Performance23.69%5.95%10.68%12.62%
1 Year Performance12.25%17.09%34.47%19.25%

NeuroOne Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NMTC
NeuroOne Medical Technologies
2.7757 of 5 stars
$0.90
-0.4%
$1.45
+61.5%
+11.1%$44.74M$5.76M-4.0820
SGHT
Sight Sciences
1.5396 of 5 stars
$3.55
+3.4%
$3.93
+11.0%
-56.3%$183.33M$79.87M-3.62210Upcoming Earnings
PROF
Profound Medical
2.6833 of 5 stars
$5.75
+3.5%
$11.00
+91.5%
-43.3%$173.96M$10.68M-4.75150News Coverage
TLSI
TriSalus Life Sciences
2.8475 of 5 stars
$4.55
-0.5%
$10.75
+136.5%
-17.8%$171.98M$29.43M-4.06106News Coverage
Gap Down
INGN
Inogen
4.24 of 5 stars
$6.37
+1.3%
$11.00
+72.7%
-27.7%$170.75M$335.70M-5.521,030
BSGM
Biosig Technologies
1.9527 of 5 stars
$6.06
+5.2%
$10.00
+65.0%
+906.6%$165.54M$26K0.0050Gap Up
High Trading Volume
KRMD
KORU Medical Systems
2.8962 of 5 stars
$3.45
-0.4%
$4.50
+30.6%
+37.1%$158.72M$33.65M-31.2780
ELMD
Electromed
1.2848 of 5 stars
$18.77
+3.6%
$33.50
+78.5%
+25.0%$157.28M$61.44M25.01160News Coverage
Analyst Forecast
Analyst Revision
PDEX
Pro-Dex
2.4819 of 5 stars
$48.01
+2.9%
$56.00
+16.7%
+159.2%$156.15M$64.12M17.10140Positive News
LNSR
LENSAR
1.3651 of 5 stars
$12.99
-2.5%
$15.00
+15.5%
+149.1%$152.92M$53.49M-2.67110Positive News
RCEL
Avita Medical
1.363 of 5 stars
$5.72
+9.8%
$16.50
+188.5%
-40.6%$150.39M$64.25M-2.60130Gap Up

Related Companies and Tools


This page (NASDAQ:NMTC) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners